The review highlights the evolving role of endoscopic ultrasound (EUS) in managing pancreatic neuroendocrine tumors (PanNETs), addressing their increasing incidence and associated diagnostic and therapeutic challenges. EUS has advanced from solely a diagnostic tool to facilitating minimally invasive locoregional therapies. Surgical intervention remains paramount, especially for localized, low-grade PanNETs larger than 2 cm. Although not routinely recommended by guidelines, EUS techniques offer alternatives for smaller lesions in patients who are unwilling or unfit for surgery.
• Why it matters: Improves treatment options for pancreatic neuroendocrine tumors using EUS.
Review by Ribeiro T, Castanheira-Rodrigues S (…) Vilas-Boas F et 6 al. in GE Port J Gastroenterol
© 2023 The Author(s).Published by S. Karger AG, Basel.
© 2023 The Author(s).Published by S. Karger AG, Basel.